Literature DB >> 7237925

Comparison of radioisotope methods for the measurement of phosphate absorption in normal subjects and in patients with chronic renal failure.

K Farrington, M N Mohammed, S P Newman, Z Varghese, J F Moorhead.   

Abstract

1. Intestinal phosphate absorption was measured in normal subjects, in patients with chronic renal failure, and in post-transplant patients, by a double isotope technique involving oral administration of 32P and simultaneous intravenous injection of 33P with subsequent deconvolution analysis. 2. By this technique intestinal phosphate absorption has been shown to have two components: an initial rapid phase, which is completed by 3 h, and a slower more prolonged phase, which continues beyond 7 1/2 h. 3. Phosphate malabsorption has been demonstrated in chronic renal failure and transplant patients, which is accounted for by impairment of the initial rapid phase of absorption. 4. Results obtained by deconvolution analysis have been compared with other estimates of phosphate absorption obtained from analysis of 32P radioactivity curves alone. 5. The fractional hourly rate of absorption and the plasma 32P radioactivity at 60 min corrected for extracellular fluid volume provided the best approximations to the result obtained by deconvolution analysis, with respect to both the maximal rate of phosphate absorption and cumulative percentage phosphate absorption.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7237925     DOI: 10.1042/cs0600055

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  8 in total

1.  Kidney Disease Progression Does Not Decrease Intestinal Phosphorus Absorption in a Rat Model of Chronic Kidney Disease-Mineral Bone Disorder.

Authors:  Colby J Vorland; Annabel Biruete; Pamela J Lachcik; Shruthi Srinivasan; Neal X Chen; Sharon M Moe; Kathleen M Hill Gallant
Journal:  J Bone Miner Res       Date:  2019-11-15       Impact factor: 6.741

Review 2.  Dietary Phosphorus Intake and the Kidney.

Authors:  Alex R Chang; Cheryl Anderson
Journal:  Annu Rev Nutr       Date:  2017-06-14       Impact factor: 11.848

3.  Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.

Authors:  Tamara Isakova; Patricia Wahl; Gabriela S Vargas; Orlando M Gutiérrez; Julia Scialla; Huiliang Xie; Dina Appleby; Lisa Nessel; Keith Bellovich; Jing Chen; Lee Hamm; Crystal Gadegbeku; Edward Horwitz; Raymond R Townsend; Cheryl A M Anderson; James P Lash; Chi-Yuan Hsu; Mary B Leonard; Myles Wolf
Journal:  Kidney Int       Date:  2011-03-09       Impact factor: 10.612

4.  Intestinal phosphate transport.

Authors:  Yves Sabbagh; Hector Giral; Yupanqui Caldas; Moshe Levi; Susan C Schiavi
Journal:  Adv Chronic Kidney Dis       Date:  2011-03       Impact factor: 3.620

5.  EOS789, a broad-spectrum inhibitor of phosphate transport, is safe with an indication of efficacy in a phase 1b randomized crossover trial in hemodialysis patients.

Authors:  Kathleen M Hill Gallant; Elizabeth R Stremke; Laurie L Trevino; Ranjani N Moorthi; Simit Doshi; Meryl E Wastney; Nozomi Hisada; Jotaro Sato; Yoshitaka Ogita; Naohisa Fujii; Yuya Matsuda; Takei Kake; Sharon M Moe
Journal:  Kidney Int       Date:  2020-10-31       Impact factor: 10.612

6.  Effects of pharmacological inhibition of the sodium-dependent phosphate cotransporter 2b (NPT2b) on intestinal phosphate absorption in mouse and rat models.

Authors:  Xiaojun Wang; Yanping Xu; Xiaohong Yu; Asim Dey; Hong Y Zhang; Charity M Zink; Derek Wodka; Gina Porter; William F Matter; Leah Porras; Charles A Reidy; Jeffrey A Peterson; Brian E Mattioni; Joseph V Haas; Mark C Kowala; John R Wetterau
Journal:  Pharmacol Res Perspect       Date:  2022-04

7.  Intestinal Phosphorus Absorption in Moderate CKD and Healthy Adults Determined Using a Radioisotopic Tracer.

Authors:  Elizabeth R Stremke; Gretchen N Wiese; Sharon M Moe; Meryl E Wastney; Ranjani N Moorthi; Kathleen M Hill Gallant
Journal:  J Am Soc Nephrol       Date:  2021-07-08       Impact factor: 14.978

Review 8.  Intestinal Phosphorus Absorption in Chronic Kidney Disease.

Authors:  Elizabeth R Stremke; Kathleen M Hill Gallant
Journal:  Nutrients       Date:  2018-09-23       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.